Back to search

National and Kapodistrian University of Athens

Μελέτη ορθοκολικού καρκίνου με μικροδορυφορική αστάθεια

Abstract

dc:description

Colorectal cancer (CRC) is the third most common cancer worldwide. Although effective screening methods have decreased incidence and mortality rates, it still constitutes one of the leading causes of cancer-related deaths. PI3k/Akt/mTOR pathway is highly activated in colorectal cancer (CRC), providing the rationale for further research and possible targeting. However, its significance in relation to the DNA mismatch repair status (MMR status) has not been previously investigated. MTOR and its downstream substrate 4EBP1, constitute key mediators of PI3k signaling with a major role. Herein, we pursue our investigation in 108 MMR proficient (pMMR) and deficient (dMMR) colorectal tumors by further evaluating immunohistochemically the phosphorylated forms of mTOR (pmTOR) and 4EBP1 (p4EBP1) proteins on paraffin-embedded tissue specimens. Their correlations with MMR status, clinicopathological data, driver gene mutations (KRAS, NRAS, BRAF) as well as their impact on patients’ overall survival have also been examined. Our results indicated a possible crosstalk between MAPK and PI3k/Akt axes, as KRAS mutations were significantly associated with pmTOR expression (p=0.004). Accordingly, pmTOR expression was not associated with p4EBP1’s (p=0.206), suggesting an mTOR independent way of phosphorylation. From multivariate survival analysis, only p4EBP1 emerged as an independent negative prognostic factor for overall survival (HR: 3.322, 95% CI: 1.110-9.945, p=0.032). Furthermore, novel evidence was provided regarding MMR status and p4EBP1 expression, as dMMR carcinomas express low levels of this protein (p=0.002), which may partially explain their more favorable outcome. In conclusion, we propose co-targeting of MAPK and PI3k/Akt pathways as a treatment strategy especially in RAS/RAF mutant CRC. We also highlight the prognostic value of p4EBP1 in CRC patients while, for the first time in literature, we try to address the question, if MMR status could be used as a selection criterion for anti-mTOR therapy.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2022

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Zouki, Dionysia
  • Ζούκη, Διονυσία

Subjects

dc:subject × 14

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/52150

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Zouki, Dionysia; Ζούκη, Διονυσία. Μελέτη ορθοκολικού καρκίνου με μικροδορυφορική αστάθεια. National and Kapodistrian University of Athens, 2022. http://hdl.handle.net/10442/hedi/52150